Delivery Order SPE2DB20D1100-SPE2DB25FD2D8

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,247.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a medical inhaler product, BREYNA 80-4.5 MCG INHALER 10.3GM, with a completion date of June 6, 2025. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $1,136.92 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, to support federal agency requirements. The order has a completion date of July 2, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $29,343.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical devices. The contract has a period of performance through March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a $9,016.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a performance period ending on June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a $2,650.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical devices, with a period of performance through November 2024. The contract is not designated as a set-aside and represents an individual delivery order against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract...
This is a $2,314.37 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a performance period through May 30, 2025. This delivery order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.39 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply item, with a completion date of July 3, 2025 and a ceiling value of $1,028.39. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,370.51 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical devices. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a ceiling value of $1,151.55 and a period of performance through April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The award is part of Amerisourcebergen's larger...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD2D8
    Delivery Order

This is a $7,339.25 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BREYNA 80-4.5 MCG INHALER 10.3GM medical devices. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 10/1/25, 9:55 AM